Introduction
KCNIP3, a member of the voltage-gated potassium (Kv) channel-interacting protein family, belongs to the recoverin branch of the EF-hand superfamily. This family comprises small calcium-binding proteins with EF-hand-like domains. KCNIP3 acts as a calcium-regulated transcriptional repressor and interacts with presenilins. Mutations in presenilin genes have been linked to Alzheimer's disease.
Description
Recombinant human KCNIP3, expressed in E. coli, is a single, non-glycosylated polypeptide chain. This protein, fused with a 20 amino acid His tag at its N-terminus, consists of 276 amino acids (residues 1-256) and has a molecular weight of 31.4 kDa. Purification of KCNIP3 is achieved using proprietary chromatographic methods.
Physical Appearance
Sterile, colorless solution, filtered for purity.
Formulation
The KCNIP3 solution is provided at a concentration of 1 mg/ml in a buffer consisting of 20mM Tris-HCl (pH 8.0), 10% glycerol, 2mM DTT, and 0.1M NaCl.
Stability
For short-term storage (2-4 weeks), the solution can be stored at 4°C. For extended storage, freezing at -20°C is recommended. To ensure optimal stability during long-term storage, consider adding a carrier protein (0.1% HSA or BSA). Repeated freezing and thawing cycles should be avoided.
Purity
Purity exceeds 90.0%, as determined by SDS-PAGE analysis.
Synonyms
Calsenilin, A-type potassium channel modulatory protein 3, DRE-antagonist modulator, Kv channel-interacting protein 3, KCNIP3, CSEN, DREAM, KCHIP3, MGC18289.
Amino Acid Sequence
MGSSHHHHHH SSGLVPRGSH MQPAKEVTKA SDGSLLGDLG HTPLSKKEGI KWQRPRLSRQ ALMRCCLVKW ILSSTAPQGS DSSDSELELS TVRHQPEGLD QLQAQTKFTK KELQSLYRGF KNECPTGLVD EDTFKLIYAQ FFPQGDATTY AHFLFNAFDA DGNGAIHFED FVVGLSILLR GTVHEKLKWA FNLYDINKDG YITKEEMLAI MKSIYDMMGR HTYPILREDA PAEHVERFFE KMDRNQDGVV TIEEFLEACQ KDENIMSSMQ LFENVI.